Saturday, June 9, 2012

Aurobindo Pharma Q4 cons PAT at Rs 108 cr


Aurobindo Pharma has announced its fourth quarter results. The company's Q4 consolidated net profit was at Rs 108 crore.

Its consolidated net sales were at Rs 1,171 crore.

Its consolidated forex gain was at Rs 103 crore.




Source: www.moneycontrol.com

Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd

No comments:

Post a Comment